Advertisement

Airway Remodeling in Asthma

  • William J. Calhoun

Abstract

In a general sense, the term remodeling means structural change to a tissue or organ that develops in response to physiologic or pathophysiologic processes. Thus, left ventricular hypertrophy can be considered a remodeling response to hypertension or aortic stenosis. In the airway, structural changes develop as a consequence of many chronic inflammatory diseases of the airway, including asthma. These structural, anatomic changes may or may not be associated with physiologic or functional alterations, which are discussed in this chapter. As applied to the airway in asthma, the term remodeling has taken on a misleadingly broader connotation to include irreversible airflow limitation, bronchial hyperresponsiveness, and a lack of physiologic improvement with otherwise effective asthma therapy. This chapter defines airway remodeling in the narrow sense of structural change of the airway as a consequence of asthma. Common changes of airway remodeling in asthma include thickening of the reticular basement membrane (RBM) (or lamina reticularis), goblet cell hyperplasia, altered matrix proteins, increased mass of airway smooth muscle, and increases in submucosal vasculature.

Keywords

Mast Cell Asthmatic Patient Fluticasone Propionate Airway Smooth Muscle Respir Crit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164(suppl):28–38. This paper represents the state of the art in airway remodeling. Although the focus is not exclusively asthma, the data presented and reviewed are of considerable interest. The author is a world authority on the histology of normal and diseased airways. CrossRefGoogle Scholar
  2. 2.
    Busse W, Elias J, Sheppard D, Banks-Schlegel S: Airway remodeling and repair. Am J Respir Crit Care Med 1999, 160:1035–1042. This review is more focused on the changes of the airway in asthma and has a somewhat broader view of the airway than the article by Jeffery [1].PubMedCrossRefGoogle Scholar
  3. 3.
    Roche WR, Beasley R, Williams JH, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520–523.PubMedCrossRefGoogle Scholar
  4. 4.
    Pohunek P, Roche WR, Turzikova J, et al.: Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 1997, 11(suppl):160.Google Scholar
  5. 5.
    van den Torrn WM, Overbeek SE, de Jongste JC, et al.: Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001, 164:2107–2113.CrossRefGoogle Scholar
  6. 6.
    Karjalainen E-M, Laitinen A, Sue-Chu M, et al.: Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med 2000, 161:2086–2091.PubMedCrossRefGoogle Scholar
  7. 7.
    Chu HW, Halliday JL, Martin RJ, et al.: Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998, 158:1936–1944.PubMedCrossRefGoogle Scholar
  8. 8.
    Elias JA: Airway remodeling in asthma: unanswered questions. Am J Respir Crit Care Med 2000, 161(suppl):168–171.CrossRefGoogle Scholar
  9. 9.
    Vignola AM, Kips J, Bousquet J: Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000, 105:1041–1053.PubMedCrossRefGoogle Scholar
  10. 10.
    Laitinen A, Akraja A, Kampe M, et al.: Tenascin is increased in airways basement membrane of asthmatics and is decreased by an inhaled steroid. Am J Respir Crit Care Med 1997, 156:951–958.PubMedCrossRefGoogle Scholar
  11. 11.
    Carroll NG, Perry S, Karkhanis A: The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. Am J Respir Crit Care Med 2000, 161:244–248.PubMedCrossRefGoogle Scholar
  12. 12.
    Huber HL, Koessler KK: The pathology of bronchial asthma. Ann Intern Med 1922, 30:689–693.CrossRefGoogle Scholar
  13. 13.
    Dunhill M: The pathology of asthma with special reference of changes in the bronchial mucosa. J Clin Pathol 1960, 13:27–33.CrossRefGoogle Scholar
  14. 14.
    Ebina M, Takahashi T, Chiba T, Montomiya M: Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis 1993, 48:720–726.CrossRefGoogle Scholar
  15. 15.
    Amrani Y, Moore PE, Hoffman R, et al.: Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am J Respir Crit Care Med 2001, 164:2098–2101.PubMedCrossRefGoogle Scholar
  16. 16.
    Ammit AJ, Hastie AT, Edsall LC, et al.: Sphingosine-1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001, 15:1212–1214.PubMedGoogle Scholar
  17. 17.
    Ammit AJ, Hoffman RK, Amrani Y, et al.: Tumor necrosis factor alpha induced secretion of RANTES and IL-6 from human airway smooth muscle cells: modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 2000, 23:794–802.PubMedCrossRefGoogle Scholar
  18. 18.
    Li X, Wilson JW: Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997, 156:229–233.PubMedCrossRefGoogle Scholar
  19. 19.
    Peat JK, Woolcock AJ, Cullen K: Rate of decline in lung function in subjects with asthma. Eur J Respir Dis 1987, 20:171–179.Google Scholar
  20. 20.
    Lange P, Parner J, Vestbo J, et al.: A 15-year followup study of ventilatory function in adults with asthma. N Engl J Med 1998, 339:1194–1200.PubMedCrossRefGoogle Scholar
  21. 21.
    Chetta A, Foresi A, Del-Donno M, et al.: Airway remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997, 111:852–857.PubMedCrossRefGoogle Scholar
  22. 22.
    Pare PD, Roberts DR, Bai TR, Wiggs BJ: The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis 1997, 52:589–598.PubMedGoogle Scholar
  23. 23.
    Huang J, Olivenstein R, Taha R, et al.: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999, 160:725–729.PubMedCrossRefGoogle Scholar
  24. 24.
    Munger JS, Harpel JG, Gleizes PE, et al.: Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int 1997, 51:1376–1382.PubMedCrossRefGoogle Scholar
  25. 25.
    Minshall EM, Leung DYM, Martin RJ, et al.: Eosinophil associated TGF-βl mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326–333.PubMedCrossRefGoogle Scholar
  26. 26.
    Reddington AE, Madden J, Frew AJ, et al.: Transforming growth factor-β1 in asthma: measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997, 156:642–647.CrossRefGoogle Scholar
  27. 27.
    Meerschaert J, Kelly EAB, Mosher DF, et al.: Segmental allergen challenge increases fibronectin in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1999, 159:619–625.PubMedCrossRefGoogle Scholar
  28. 28.
    Zheng T, Zhu Z, Wang J, et al.: IL-11: insights in asthma from overexpression transgenic modeling. J Allergy Clin Immunol 2001, 108:489–496.PubMedCrossRefGoogle Scholar
  29. 29.
    Tang W, Geba GP, Zheng T, et al.: Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996, 98:2845–2853.PubMedCrossRefGoogle Scholar
  30. 30.
    Wills-Karp M, Luyimbazi J, Xu X, et al.: IL-13: central mediator of allergic asthma. Science 1998, 282:2258–2261.PubMedCrossRefGoogle Scholar
  31. 31.
    Blease K, Jakubzick C, Westwick J, et al.: Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 2001, 166:5219–5224.PubMedGoogle Scholar
  32. 32.
    Richter A, Puddicombe SM, Lordan JL, et al.: The contribution of IL-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001, 25:385–391.PubMedCrossRefGoogle Scholar
  33. 33.
    Molet S, Hamid Q, Davoine F, et al.: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430–438.PubMedCrossRefGoogle Scholar
  34. 34.
    Sommerhoff CP: Mast cell tryptases and airway remodeling. Am J Respir Crit Care Med 2001, 164(suppl):52–58. This review of mast cell tryptases is full of important insights and three-dimensional molecular modeling. Readers interested in specifics of these important molecules are encouraged to read this article.CrossRefGoogle Scholar
  35. 35.
    Berger P, Perng D-W, Thabrew H, et al.: Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 2001, 91:1371–1379.Google Scholar
  36. 36.
    Henderson WR Jr, Tang L-O, Chu S-J, et al.: A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002, 165:108–116. This is arguably the most important paper in the past year in the field of leukotriene biology. In a relevant animal model, the authors demonstrate important effects of antileukotriene therapy on inflammation and particularly on structural changes (ie, remodeling) of the airway.PubMedCrossRefGoogle Scholar
  37. 37.
    Page S, Ammit AJ, Black JL, Armour CL: Human mast cells and airway smooth muscle interactions: implications for asthma. Am J Physiol Lung Cell Molec Physiol 2001, 281:1313–1323. This lengthy review of mast cells and smooth muscle cells and their interactions is highly recommended for its readability, content, and insights.Google Scholar
  38. 38.
    Palmans E, Kips JC, Pauwels RA: Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000, 161:627–635.PubMedCrossRefGoogle Scholar
  39. 39.
    Kelly EAB, Busse WW, Jarjour NN: Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000, 162:1157–1161.PubMedCrossRefGoogle Scholar
  40. 40.
    Vignola AM, Riccobono L, Miarbella A, et al.: Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998, 158:1945–1950.PubMedCrossRefGoogle Scholar
  41. 41.
    Tschumperlin DJ, Drazen JM: Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med 2001, 164(suppl):90–94.CrossRefGoogle Scholar
  42. 42.
    Swartz MA, Tschumperlin DJ, Drazen JM: Mechanical stress is communicated between different cell types to elicit matrix remodeling. Proc Nat Acad Sci USA 2001, 98:6180–6185.PubMedCrossRefGoogle Scholar
  43. 43.
    Olivieri D, Chetta A, Del Donno M, et al.: Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997, 155:1864–1871.PubMedCrossRefGoogle Scholar
  44. 44.
    Orsida BE, Ward C, Li X, et al.: Effect of a long-acting beta agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001, 164:117–121.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • William J. Calhoun

There are no affiliations available

Personalised recommendations